- Letter to the editor: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
-
Kadihasanoglu M, Ozbek E
- KMID: 2359878
- Korean J Urol.
- 2015 Dec;56(12):845-846.
- doi: 10.4111/kju.2015.56.12.845
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The authors reply: Korean clinical practice guideline for benign prostatic hyperplasia
-
Yeo JK, Kim HJ
- KMID: 2426510
- Investig Clin Urol.
- 2016 Jul;57(4):305-305.
- doi: 10.4111/icu.2016.57.4.305
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The authors reply: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
-
Kabir A, Cyrus A
- KMID: 2359879
- Korean J Urol.
- 2015 Dec;56(12):847-848.
- doi: 10.4111/kju.2015.56.12.847
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter to the editor: Korean clinical practice guideline for benign prostatic hyperplasia
-
Jung JH, Dahm P
- KMID: 2426509
- Investig Clin Urol.
- 2016 Jul;57(4):303-304.
- doi: 10.4111/icu.2016.57.4.303
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of intraprostatic architecture and regrowth velocity for considering discontinuation of dutasteride after combination therapy with an alpha blocker: A prospective, pilot study
-
Shindo T, Hashimoto , Shimizu T, Itoh N, Masumori N
- KMID: 2155306
- Korean J Urol.
- 2015 Apr;56(4):305-309.
- doi: 10.4111/kju.2015.56.4.305
PURPOSE: We conducted a prospective single-center study to evaluate the possibility of discontinuation of dutasteride after combination therapy with an alpha blocker for benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
